Biblio

Export 3170 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
M. Carmona-Iragui, Fernández-Arcos, A., Alcolea, D., Piazza, F., Morenas-Rodriguez, E., Antón-Aguirre, S., Sala, I., Clarimón, J., Dols-Icardo, O., Camacho, V., Sampedro, F., Munuera, J., Nuñez-Marin, F., Lleo, A., Fortea, J., Gómez-Ansón, B., and Blesa, R., “Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
M. Carmona-Iragui, Santos, T., Videla, S., Fernández, S., Benejam, B., Videla, L., Alcolea, D., Blennow, K., Blesa, R., Lleo, A., and Fortea, J., “Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1489-1496, 2017.
S. Carnemolla, Kumfor, F., Liang, C. Tao, Foxe, D., Ahmed, R., and Piguet, O., “Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 1, pp. 51-66, 2022.
A. Carotenuto, Rea, R., Traini, E., Fasanaro, A. Maria, Ricci, G., Manzo, V., and Amenta, F., “The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.”, J Alzheimers Dis, vol. 56, no. 2, pp. 805-815, 2017.
A. Casamitjana, Petrone, P., Tucholka, A., Falcon, C., Skouras, S., Molinuevo, J. Luis, Vilaplana, V., and Gispert, J. Domingo, “MRI-Based Screening of Preclinical Alzheimer's Disease for Prevention Clinical Trials.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1099-1112, 2018.
R. Cascella, Evangelisti, E., Bigi, A., Becatti, M., Fiorillo, C., Stefani, M., Chiti, F., and Cecchi, C., “Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload.”, J Alzheimers Dis, vol. 60, no. 3, pp. 923-938, 2017.
S. Cascini, Agabiti, N., Marino, C., Acampora, A., Balducci, M., Calandrini, E., Davoli, M., and Bargagli, A. Maria, “Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.”, J Alzheimers Dis, vol. 89, no. 2, pp. 681-693, 2022.
R. J. Castellani and Perry, G., “Dementia Pugilistica Revisited.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1209-1221, 2017.
R. J. Castellani and Perry, G., “Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges.”, J Alzheimers Dis, vol. 67, no. 2, pp. 447-467, 2019.
R. J. Castellani, Shanes, E., McCord, M., Reish, N. J., Flanagan, M. E., Mesulam, M. - M., and Jamshidi, P., “Neuropathology of Anti-Amyloid-β Immunotherapy: A Case Report.”, J Alzheimers Dis, vol. 93, no. 2, pp. 803-813, 2023.
C. - A. Castellano, Paquet, N., Dionne, I. J., Imbeault, H., Langlois, F., Croteau, E., Tremblay, S., Fortier, M., J Matte, J., Lacombe, G., Fülöp, T., Bocti, C., and Cunnane, S. C., “A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1459-1468, 2017.
J. M. Castellano, Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., Goate, A. M., Bales, K. R., Paul, S. M., Bateman, R. J., and Holtzman, D. M., “Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.”, Sci Transl Med, vol. 3, no. 89, p. 89ra57, 2011.
C. Castillo, Bravo-Arrepol, G., Wendt, A., Saez-Orellana, F., Millar, C., Burgos, C. F., Gavilán, J., Pacheco, C., Ahumada-Rudolph, R., Napiórkowska, M., Pérez, C., Becerra, J., Fuentealba, J., and Cabrera-Pardo, J. R., “Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-β Peptide Toxicity.”, J Alzheimers Dis, vol. 94, no. s1, pp. S97-S108, 2023.
F. J. Castora, Kerns, K. A., Pflanzer, H. K., Hitefield, N. L., Gershon, B., Shugoll, J., Shelton, M., and Coleman, R. A., “Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 90, no. 1, pp. 119-137, 2022.
M. Cations, Draper, B., Low, L. - F., Radford, K., Trollor, J., Brodaty, H., Sachdev, P., Gonski, P., Broe, G. Anthony, and Withall, A., “Non-Genetic Risk Factors for Degenerative and Vascular Young Onset Dementia: Results from the INSPIRED and KGOW Studies.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1747-1758, 2018.
E. Cavedo, Suppa, P., Lange, C., Opfer, R., Lista, S., Galluzzi, S., Schwarz, A. J., Spies, L., Buchert, R., and Hampel, H., “Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's ”, J Alzheimers Dis, vol. 60, no. 1, pp. 151-164, 2017.
M. G. Cavuoto, Ong, B., Pike, K. E., Nicholas, C. L., Bei, B., and Kinsella, G. J., “Better Objective Sleep Quality in Older Adults with High Subjective Memory Decline.”, J Alzheimers Dis, vol. 53, no. 3, pp. 943-53, 2016.
G. Cebers, Alexander, R. C., Haeberlein, S. Budd, Han, D., Goldwater, R., Ereshefsky, L., Olsson, T., Ye, N., Rosen, L., Russell, M., Maltby, J., Eketjäll, S., and Kugler, A. R., “AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1039-1053, 2017.
K. Cechova, Andel, R., Angelucci, F., Chmatalova, Z., Marková, H., Laczó, J., Vyhnálek, M., Matoska, V., Kaplan, V., Nedelska, Z., Ward, D. D., and Hort, J., “Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 1, pp. 247-257, 2020.
C. Cerami, Dodich, A., Greco, L., Iannaccone, S., Magnani, G., Marcone, A., Pelagallo, E., Santangelo, R., Cappa, S. F., and Perani, D., “The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.”, J Alzheimers Dis, vol. 55, no. 1, pp. 183-197, 2017.
P. Cermakova, Nelson, M., Secnik, J., Garcia-Ptacek, S., Johnell, K., Fastbom, J., Kilander, L., Winblad, B., Eriksdotter, M., and Religa, D., “Living Alone with Alzheimer's Disease: Data from SveDem, the Swedish Dementia Registry.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1265-1272, 2017.
J. Augusto Fe Cestari, Fabri, G. Maria Camp, Kalil, J., Nitrini, R., Jacob-Filho, W., de Siqueira, J. Tadeu Tess, and Siqueira, S. Regina D. T., “Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1479-85, 2016.
K. Ceyzériat, Tournier, B. B., Millet, P., Dipasquale, G., Koutsouvelis, N., Frisoni, G. B., Garibotto, V., and Zilli, T., “Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice.”, J Alzheimers Dis, vol. 86, no. 2, pp. 641-653, 2022.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, “Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
Y. Ling Chai, Xing, H., Chong, J. R., Francis, P. T., Ballard, C. G., Chen, C. P., and Lai, M. K. P., “Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 793-801, 2018.

Pages